Interim Report July–September 2018
Third Quarter
- Revenue increased by 16.3% to €167.4m (€144.0m). Organic revenue grew by 13.8%.
- Operating profit amounted to €7.4m (€8.5m), representing an operating margin of 4.4% (5.9%).
- Net profit amounted to €6.2m (€4.3m), which represents a net profit margin of 3.7% (3.0%).
- Cash flow from operating activities amounted to €21.8m (€15.3m).
- Basic/diluted earnings per share (EPS) were €0.042 (€0.030).
- EBITDA increased by 0.7% to €15.1m (€15.0m), corresponding to an EBITDA margin of 9.0% (10.4%).
Nine Months
- Revenue increased by 14.7% to €490.4m (€427.5m). Organic revenue grew by 13.9%.
- Net profit amounted to €22.6m (€11.0m), which represents a net profit margin of 4.6% (2.6%).
- EBITDA increased by 7.9% to €43.6m (€40.4m), corresponding to an EBITDA margin of 8.9% (9.5%)
REVENUE AND EARNINGS
| € millions (€m) | Q3 2018 | Q3 2017 | Growth | 9M 2018 | 9M 2017 | Growth | FY 2017 |
| Revenue | 167.4 | 144.0 | 16% | 490.4 | 427.5 | 15% | 580.2 |
| Operating profit | 7.4 | 8.5 | -13% | 21.9 | 21.0 | 4% | 28.8 |
| Operating profit margin, % | 4.4% | 5.9% | 4.5% | 4.9% | 5.0% | ||
| Net profit | 6.2 | 4.3 | 44% | 22.6 | 11.0 | 105% | 20.2 |
| Net profit margin, % | 3.7% | 3.0% | 4.6% | 2.6% | 3.5% | ||
| Earnings per share, € | 0.042 | 0.030 | 40% | 0.159 | 0.085 | 87% | 0.157 |
| Diluted earnings per share, € | 0.042 | 0.030 | 40% | 0.159 | 0.085 | 87% | 0.157 |
| EBITDA | 15.1 | 15.0 | 1% | 43.6 | 40.4 | 8% | 55.0 |
| EBITDA margin, % | 9.0% | 10.4% | 8.9% | 9.5% | 9.5% |
For Alternative Performance Measure definitions and reconciliations, refer to note 8
Contact information
For further information, please contact:
Paula Treutiger, Director Corporate Communications & Investor Relations
Phone: +46 73 366 65 99
E-mail: paula.treutiger@medicover.com
This information is information that Medicover AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 8.00 (CEST) on 26 October 2018. This interim report and other information about Medicover, is available at medicover.com.
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2017, Medicover had revenue around €580 million and 15,900 employees. For more information, go to www.medicover.com.
Tags: